Phase 2 trial (NCI-COTC030) of adjuvant inhaled recombinant human IL-15 combined with amputation and adjuvant chemotherapy in dogs with appendicular osteosarcoma
一项针对患有四肢骨肉瘤的犬的II期临床试验（NCI-COTC030）研究了吸入重组人IL-15辅助疗法联合截肢和辅助化疗的疗效。
期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2025.1672790
Rebhun, Robert B; Cruz, Sylvia M; York, Daniel; Mazcko, Christina N; Razmara, Aryana M; Patkar, Sushant; Judge, Sean J; Sholevar, Cyrus J; Shah, Ravi K; Zamora, Anthony E; Al-Nadaf, Sami; Vail, David M; Fan, Timothy M; Burton, Jenna H; Luker, Madison E; Skorupski, Katherine A; Lejeune, Amandine T; Woolard, Kevin; Stewart, Susan L; Sparger, Ellen E; Young, Jacque; Cohen-Davidyan, Tamar; Huang, Erich; Beck, Jessica A; Murphy, William J; Kent, Michael S; Culp, William T N; LeBlanc, Amy K; Canter, Robert J
